Investor Alerts Required fields denoted by an asterisk (). Alert type Quote SEC Filing Event News Email IR Side Nav Overview Press Releases Events & Presentations Media Materials Corporate Governance Annual General Meeting Hauptversammlung Stock Information Financials Overview Annual Reports (20-F) Quarterly Reports SEC Filings Organizational Actions Form 8937 Analyst Coverage Shareholder Services Toolkit Information Requests Corporate Presentation Sign up for Email Alerts RSS Feeds Media Contact Jasmina Alatovic Senior Manager Global External CommunicationsMedia@biontech.de +49 6131 9084-1513 Investor Contact Sylke Maas, Ph.D. VP Investor Relations & Business StrategyInvestors@biontech.de +49 6131 9084-0 For U.S. Investors: Westwicke Victoria Meissner, M.D.victoria.meissner@westwicke.com +1 646 677-1837 Whistleblower Hotline BioNTech Hotline (anonymous) Germany: 0800 000-8972 US: 844 901-0271 Other: +1 757 278-0107 Online Access to Whistle Blowing Reporting Or by Email
Investor Alerts Required fields denoted by an asterisk (). Alert type Quote SEC Filing Event News Email
